Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vardenafil dihydrochloride (Levitra) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 46.00 | |
50 mg | Inquiry | $ 84.00 | |
100 mg | Inquiry | $ 153.00 | |
200 mg | Inquiry | $ 270.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 81.00 |
Description | Vardenafil dihydrochloride (Levitra) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively. |
Targets&IC50 | PDE5:0.7 nM (Cell-free), PDE1:180 nM (Cell-free) |
In vitro | Vardenafil specifically inhibits the hydrolysis of cGMP by PDE5 with an IC50 of 0.7 nM (6.6 nM). Vardenafil significantly enhances the SNP-induced relaxation of human trabecular smooth muscle at 3 nM (10 nM). Vardenafil also significantly potentiates both ACh-induced and transmural electrical stimulation-induced relaxation of trabecular smooth muscle. Vardenafil (100 mM) increases cyclic GMP levels in rat hippocampal slices. Vardenafil, tadalafil, and Sildenafil each competitively inhibit cGMP hydrolysis by phosphodiesterase-5 (PDE5), thereby fostering cGMP accumulation and relaxation of vascular smooth muscle. |
In vivo | Vardenafil dose-dependently potentiates erectile responses to intravenously administered sodium nitroprusside in rabbit. Vardenafil (3 mg/kg, p.o.) results in an improved object discrimination performance in rats. Vardenafil (30 mg/L, p.o.) increases both iNOS and proliferating cell nuclear antigen expression (SM cell replication) in rats, with normalization of the dynamic infusion cavernosometry drop rate and SM/collagen ratio. Vardenafil induces powerful preconditioning-like cardioprotective effect against ischemia/reperfusion injury through the opening of mitochondrial K(ATP) channels in the heart of rabbit. Vardenafil protects the ischemic myocardium against reperfusion injury through a mechanism dependent on mitochondrial K(ATP) channel opening. |
Synonyms | Levitra, Vardenafil Hydrochloride |
Molecular Weight | 561.52 |
Formula | C23H34Cl2N6O4S |
CAS No. | 224789-15-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL (17.27 mM)
Ethanol: 16 mg/mL (27.6 mM)
DMSO: 93 mg/mL (160.6 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vardenafil dihydrochloride 224789-15-5 Metabolism PDE cGMP Levitra erectile dysfunction impotence Vardenafil Pharmacokinetics erectile selective zucker diabetic fatty rats inhibit smooth diabetes Inhibitor Endogenous Metabolite hepatitis dysfunction muscle Vardenafil Hydrochloride stimulation Vardenafil Dihydrochloride Phosphodiesterase (PDE) inhibitor